Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 108 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,683,000 | -49.8% | 55,666 | -17.8% | 0.00% | -66.7% |
| Q4 2020 | $3,353,000 | +26.5% | 67,724 | -1.9% | 0.00% | +50.0% |
| Q3 2020 | $2,650,000 | -8.6% | 69,024 | +2.8% | 0.00% | -33.3% |
| Q2 2020 | $2,900,000 | +119.2% | 67,124 | +32.4% | 0.00% | +50.0% |
| Q1 2020 | $1,323,000 | +7.4% | 50,693 | +28.6% | 0.00% | +100.0% |
| Q4 2019 | $1,232,000 | +385.0% | 39,433 | +303.9% | 0.00% | – |
| Q3 2019 | $254,000 | – | 9,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |